Vaccinia virus biochemical genetics
Vaccinia virus biochemical genetics
批准号:
7741666
负责人:
Richard C Condit
金额:
$36.26万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-07-01 至 2013-11-30
关键词:
BindingBiochemicalBiochemical GeneticsCellsCodeComplexCoupledDNADNA Replication FactorDNA biosynthesisDNA replication forkDNA-Directed RNA PolymeraseDNA-dependent ATPaseDiseaseElongation FactorEndoribonucleasesEnzymesEssential GenesEukaryotaEventGene ExpressionGene Expression RegulationGenesGenetic RecombinationGenetic TranscriptionGoalsIn VitroIntegration Host FactorsMediatingMessenger RNAModelingMolecularNucleic Acid BindingPhosphoproteinsPhosphorylationPlayPoxviridaeProcessProkaryotic CellsPropertyProteinsPublic HealthRNAReactionRecombinant ProteinsRegulationResearchRoleSmall Interfering RNASourceStudy modelsSystemTestingTranscription ElongationTranscriptional RegulationVacciniaVaccinia virusViralViral ProteinsVirusVirus DiseasesVirus ReplicationVirus-Cell Membrane InteractionWorkdesignendoribonucleasehelicasein vivoinsightinterestmutantoncolytic vectorpublic health relevancereconstitutionrelease factorresearch studytermination factortherapeutic proteintooltranscription terminationviral DNAviral RNAweapons
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The goal of this project is to understand the molecular mechanisms governing post-initiation events in postreplicative gene transcription during vaccinia virus infection. In recent years it has become increasingly clear that post-initiation events in transcription, including transcription elongation, termination and RNA cleavage, comprise important control points for regulation of gene expression in both prokaryotes and eukaryotes. Our recent work suggests that postreplicative mRNA 3' end formation during vaccinia virus infection is a concerted process that involves both transcription termination and RNA cleavage, that it is coupled to viral DNA replication, and that it is mediated by both viral and host factors in a dynamic complex. The factors include a viral RNA release factor (A18), a viral RNA cleavage/transcription/DNA replication factor (H5), two viral positive transcription elongation factors (G2 and J3), and at least two host factors required for A18 RNA release activity and for RNA cleavage. This project comprises two aims, focusing on understanding the mechanism of transcription termination and endoribonucleolytic RNA cleavage. Studies of termination (Aim 1) involve mechanistic studies on A18 and its required host factor, and studies of mRNA cleavage (Aim 2) involve mechanistic studies of an endoribonuclease comprised of the viral H5 protein and host proteins. The viral gene products under study are highly conserved among vertebrate poxviruses, they are essential for virus replication, they all unquestionably collaborate in mediating postreplicative gene transcription elongation and termination, and yet their precise roles in these processes are only partially understood. The research proposed here will significantly refine our understanding of the roles of these essential genes in poxvirus replication, and it will also impact on our understanding of the interaction between the virus and the host cell. The results will provide critical insight into fundamental mechanisms of vaccinia virus gene expression in particular, and the system may prove to be an important model for study of regulation of transcription elongation in eukaryotes in general. PUBLIC HEALTH RELEVANCE: This project is relevant to public health on three levels. First, it advances our understanding of the basic mechanisms of eukaryotic transcriptional regulation of gene expression, which in turn is a central part of the normal framework on which our understanding of disease is built. Second, it advances our understanding of the molecular mechanisms of virus replication and virus cell interactions, which has implications in general for treatment of virus induced disease. Third, the project provides insight specifically into the replication of poxviruses, which are of particular interest to public health as research tools, as a source of therapeutic proteins, as oncolytic vectors, and as potential bioterrorist weapons.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vaccinia virus biochemical genetics
-
批准号:8053536
-
项目类别:
-
资助金额:$10.14万
-
财政年份:2010
-
负责人:Richard C Condit
-
依托单位:
Vaccinia virus genetics and morphogenesis
-
批准号:8651851
-
项目类别:
-
资助金额:$36.26万
-
财政年份:2004
-
负责人:Richard C Condit
-
依托单位:
Vaccinia Virus Genetics and Morphogenesis
-
批准号:7211358
-
项目类别:
-
资助金额:$30.83万
-
财政年份:2004
-
负责人:Richard C Condit
-
依托单位:
Vaccinia Virus Genetics and Morphogenesis
-
批准号:7032232
-
项目类别:
-
资助金额:$31.75万
-
财政年份:2004
-
负责人:Richard C Condit
-
依托单位:
Vaccinia Virus Genetics and Morphogenesis
-
批准号:7388920
-
项目类别:
-
资助金额:$30.24万
-
财政年份:2004
-
负责人:Richard C Condit
-
依托单位:
Vaccinia virus genetics and morphogenesis
-
批准号:8068667
-
项目类别:
-
资助金额:$36.26万
-
财政年份:2004
-
负责人:Richard C Condit
-
依托单位:
Vaccinia virus genetics and morphogenesis
-
批准号:8447581
-
项目类别:
-
资助金额:$34.08万
-
财政年份:2004
-
负责人:Richard C Condit
-
依托单位:
Vaccinia virus genetics and morphogenesis
-
批准号:7983671
-
项目类别:
-
资助金额:$36.63万
-
财政年份:2004
-
负责人:Richard C Condit
-
依托单位:
Vaccinia virus genetics and morphogenesis
-
批准号:8260228
-
项目类别:
-
资助金额:$36.26万
-
财政年份:2004
-
负责人:Richard C Condit
-
依托单位:
Vaccinia Virus Genetics and Morphogenesis
-
批准号:6780031
-
项目类别:
-
资助金额:$18.96万
-
财政年份:2004
-
负责人:Richard C Condit
-
依托单位:
Vaccinia Virus Genetics and Morphogenesis
-
批准号:6872217
-
项目类别:
-
资助金额:$32.51万
-
财政年份:2004
-
负责人:Richard C Condit
-
依托单位:
Vaccinia Virus Genetics and Morphogenesis
-
批准号:6666526
-
项目类别:
-
资助金额:$29.02万
-
财政年份:2003
-
负责人:Richard C Condit
-
依托单位:
VACCINIA VIRUS BIOCHEMICAL GENETICS
-
批准号:3127683
-
项目类别:
-
资助金额:$19.39万
-
财政年份:1990
-
负责人:Richard C Condit
-
依托单位:
VACCINIA VIRUS BIOCHEMICAL GENETICS
-
批准号:3127677
-
项目类别:
-
资助金额:$22.59万
-
财政年份:1990
-
负责人:Richard C Condit
-
依托单位:
VACCINIA VIRUS BIOCHEMICAL GENETICS
-
批准号:2614877
-
项目类别:
-
资助金额:$30.0万
-
财政年份:1990
-
负责人:Richard C Condit
-
依托单位:
VACCINIA VIRUS BIOCHEMICAL GENETICS
-
批准号:2413510
-
项目类别:
-
资助金额:$25.54万
-
财政年份:1990
-
负责人:Richard C Condit
-
依托单位:
VACCINIA VIRUS BIOCHEMICAL GENETICS
-
批准号:2060635
-
项目类别:
-
资助金额:$24.55万
-
财政年份:1990
-
负责人:Richard C Condit
-
依托单位:
Vaccinia virus biochemical genetics
-
批准号:8196849
-
项目类别:
-
资助金额:$35.9万
-
财政年份:1990
-
负责人:Richard C Condit
-
依托单位:
Vaccinia virus biochemical genetics
-
批准号:7989995
-
项目类别:
-
资助金额:$35.9万
-
财政年份:1990
-
负责人:Richard C Condit
-
依托单位:
VACCINIA VIRUS BIOCHEMICAL GENETICS
-
批准号:2060634
-
项目类别:
-
资助金额:$23.36万
-
财政年份:1990
-
负责人:Richard C Condit
-
依托单位:
海外基金